New Delhi: Phase II/III clinical trials of Covaxin, indigenous COVID-19 vaccine, in the 2-18-year-olds will begin in the next 10-12 days, senior NITI Aayog member VK Paul announced on Tuesday.
“COVAXIN has been approved by the Drugs Controller General of India (DCGI), for Phase II/III clinical trials in the age group of 2 to 18 years. I have been told that trials will begin in the next 10-12 days,” said Dr VK Paul, Member-Health, NITI Aayog.
The trial will take place in 525 subjects at various sites, NDTV reported.
Mumbai: Lalita D'Silva, Taimur's former nanny, expressed her disbelief over the news of the seven-year-old…
Pune: As many as 59 people have been diagnosed with Guillain-Barre Syndrome (GBS), a rare…
Baripada: Forest officials on Thursday rescued a fishing cat was rescued from a canal near…
Balasore: Excise officials have seized brown sugar worth more than Rs 7 lakh and arrested…
Lahore: In a bid to tighten control over social media, Pakistan is set to bring…
Bhubaneswar: The BJD has taken a strong exception to the statement of Odisha Assembly Speaker…
This website uses cookies.
